Aakaar Medical Technologies Limited is a specialized medical aesthetics company offering a broad portfolio of cosmetic products and devices. Their offerings include both own brands—comprising domestically manufactured products and internationally manufactured devices—and imported brands distributed from countries such as Korea, Spain, Italy, and Austria. This diverse product range positions the company as a key player in the fast-growing medical aesthetics segment in India.

IPO Details

The company is launching a Book Built Issue IPO of ₹27.00 Crores, entirely via a Fresh Issue of 37.50 lakh equity shares. The IPO subscription window opens on June 20, 2025, and closes on June 24, 2025. The share allotment is expected by June 25, 2025, with a tentative listing date on the NSE SME platform set for June 27, 2025.

The price band is fixed between ₹68 to ₹72 per equity share. At the upper price band, the company’s market capitalization at IPO will be approximately ₹102.04 Crores. The IPO lot size is 1,600 shares, meaning retail investors must invest a minimum of ₹1,15,200, and High-Net-Worth Individuals (HNIs) must apply for at least 2 lots (3,200 shares), totaling ₹2,30,400.

Lead Manager and Registrar

Indorient Financial Services Limited is the Book Running Lead Manager for the IPO. Bigshare Services Private Limited acts as the Registrar, and Alacrity Securities Limited is the Market Maker.

Grey Market Premium (GMP)

Currently, the Grey Market Premium (GMP) for Aakaar Medical Technologies IPO is ₹0, reflecting no expected listing gains based on current market sentiment and the company’s financial performance. GMP figures are unofficial and influenced by unregulated market demand and supply; hence, investors should use this information cautiously and for educational purposes only.

Live Subscription Status

As of 7:00 PM on June 20, 2025, the IPO has been subscribed 0.34 times on the first day, indicating moderate initial investor interest. Real-time subscription updates are available on NSE’s official website.

How to Check IPO Allotment Status

Investors can check their IPO allotment status from June 25, 2025, onwards via the registrar’s website by:

• Selecting Aakaar Medical Technologies Limited IPO from the IPO list,

• Entering application number, PAN, or DP Client ID, and

• Submitting the details to view the allotment results.

Objectives of the IPO

The company plans to deploy the net proceeds as follows:

1. Approximately ₹20.35 Crores for funding working capital requirements, ensuring smooth operations and business expansion.

2. The remaining funds will be utilized for general corporate purposes.

Promoters and Management

Promoted by Dilip Ramesh Meswani, who has over 24 years of experience in the medical aesthetics sector, along with Bindi Dilip Meswani, who brings more than 10 years of expertise, the promoters have demonstrated strong leadership in the company’s growth trajectory.

Financial Performance

Aakaar Medical Technologies has shown a steady and robust financial growth over recent years:

The company’s key financial ratios include a pre-issue EPS of ₹6.13 and a post-issue EPS of ₹4.26 for FY24. The pre-issue Price-to-Earnings (P/E) ratio stands at 11.74x, while the post-issue P/E is at 16.90x, reflecting a fairly priced IPO. The Return on Capital Employed (ROCE) for FY24 is 21.02%, and both Return on Equity (ROE) and Return on Net Worth (RoNW) are strong at 33.81%, showcasing efficient use of capital and profitability.

Investment Outlook

Given the company’s consistent financial growth, strong promoter experience, and the IPO’s fair pricing, the Aakaar Medical Technologies IPO may be considered by investors with a medium to long-term horizon. However, the zero Grey Market Premium indicates limited or no immediate listing gains, suggesting that the IPO might not be suitable for investors seeking quick returns.

Conclusion

Aakaar Medical Technologies’ IPO offers an opportunity to invest in a niche, growing medical aesthetics sector with a diversified product portfolio and steady financials. Investors should evaluate their risk tolerance and consider professional advice before investing.

Disclaimer:
This article is for informational and educational purposes only and does not constitute financial advice or a solicitation to buy or sell securities. Investors should perform their own due diligence and consult financial advisors prior to investing. Grey Market Premium (GMP) values are unofficial and subject to change. All investments carry market risks, and past performance is not indicative of future results.

The Upcoming IPOs in this week and coming weeks are Supertech EV, Valencia India, Neetu Yoshi, Abram Food, PRO FX Tech, Suntech Infra Solutions, Shri Hare-Krishna Sponge Iron, Icon Facilitators, Ace Alpha Tech, Globe Civil Projects, Sambhav Steel Tubes, Ellenbarrie Indutrial Gases, Kalpataru, HDB Financials, AJC Jewel.

The Current active IPO are  Aakaar Medical Technologies, Safe Enterprises Retail Fixtures, Mayasheel Ventures.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.